leila zarei

Dr. leila zarei


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 January 2021 in BMC Public Health
Verified
Journal Article
Open access
PDF file
SHSeyed Taghi Heydari
Seyed Taghi Heydari
LZleila zarei
leila zarei
ASAhmad Kalateh Sadati
Ahmad Kalateh Sadati
NMNajmeh Moradi
Najmeh Moradi
MAMaryam Akbari
Maryam Akbari
KLKamran Bagheri Lankarani
Kamran Bagheri Lankarani
Background: The COVID-19 outbreak is a global pandemic, during which the community preventive and protective behaviors play a crucial role in the containment and control of infection. This study was designed to contribute to the existing knowledge on how risk communication (RC) and risk perception (RP) affect protective and preventive behaviors (PPB) during the COVID-19 outbreak.Methods: The required data were extracted from a national online survey of Iranian adults aged 15 and older during March 15–19, 2020 (n=3213). Data analysis was performed using structural equation modeling.Results: The study findings reveal that RC has direct and indirect positive effects on PB. Furthermore, this study also provides new evidence indicating that RP mediates the relationship between RC and PB and there is a two-way relationship between RC and RP. These interactions may have impact on risk communication strategies which should be adopted during this pandemic.Conclusion: The study findings have remarkable implications for informing future communications as well as interventions during this ongoing outbreak and subsequent national risk events.

19 August 2020 in Nursing Open
Verified
Journal Article
Open access
PDF file
ASAhmad Kalateh Sadati
Ahmad Kalateh Sadati
LZleila zarei
leila zarei
SSSaeed Shahabi
Saeed Shahabi
SHSeyed taghi Heydari
Seyed taghi Heydari
VTVajihe Taheri
Vajihe Taheri
KLKamran Bagheri Lankarani
Kamran Bagheri Lankarani
Aim: The global outbreak of coronavirus in 2020 was considered as a serious risk for healthcare providers, especially nurses. This study aimed to investigate nurses’ perceptions and experiences of COVID‐19 outbreak in Iran.Design: This thematic analysis study was conducted in March 2020.Method: Semi‐structured interviews were conducted with 24 nurses in Qazvin, Arak, Shiraz and Kashan cities of Iran.Results: It was found out that all the participants had faced a mysterious world created by the virus. No one had clear understanding of the new virus and knew how to tackle with such a virus. In this case, the main experiences were related to defected preparedness, the worst perceived risk, family protection, social stigma and sacrificial commitment. Urgent preparedness of facilities in such outbreaks is inevitable. Accordingly, psycho‐social support of nurses and their families and strengthening their sacrificial commitments are proposed in these conditions.

1 November 2016 in Journal of Cleaner Production
Verified
Journal Article
Closed access
GMGholamhossein Mehralian
Gholamhossein Mehralian
JNJamal A. Nazari
Jamal A. Nazari
LZleila zarei
leila zarei
HRHamid Reza Rasekh
Hamid Reza Rasekh

28 February 2019 in Cost Effectiveness and Resource Allocation
Verified
Journal Article
Open access
PDF file
NMNajmeh Moradi
Najmeh Moradi
ARArash Rashidian
Arash Rashidian
SNShirin Nosratnejad
Shirin Nosratnejad
AMAlireza Olyaee Manesh
Alireza Olyaee Manesh
MZMarzieh Zanganeh
Marzieh Zanganeh
LZleila zarei
leila zarei
Recent years have witnessed a strong tendency to apply economic evidence as a guide for making health resource allocation decisions, especially those related to reimbursement policies. One such measure is the use of the cost-effectiveness threshold as a benchmark. This study explored the threshold for use in the health system of Iran by determining society’s preferences. A cross-sectional household survey based on the contingent valuation method was administered to a representative general population of 1002 in Tehran, Iran from April to June 2015. The survey was intended to estimate the respondents’ willingness-to-pay (WTP) preferences for one quality-adjusted life year (QALY) gained. The valuation scenarios featured 12 vignettes on mild to severe diseases that can change people’s quality of life. The mean of WTP for QALY was estimated using different health instruments, and the determinants of such willingness were analyzed using the Heckman selection model. WTP for QALY varied depending on the severity of a disease and the instrument used to determine health preferences. Mean low health state value were associated with high valuation. The best estimated WTP values ranged from US$1032 to US$2666 and 0.22–0.56 of Iran’s local gross domestic product (GDP) per capita in 2014. Except for educational level, significant variables differed across different disease scenarios. Generally, a high health state valuation for target diseases, high income, high educational level, and being married were associated with high WTP for QALY. From the general public’s perspective, the monetary value of QALY for mild to severe diseases with no risk of death was less than one GDP per capita. Therefore, the obtained valuation range is recommended as reference only for the adoption of interventions designed to improve quality of life. Future studies should estimate the threshold of interventions for life-threatening diseases or formulate transparent policies in such contexts.

2 April 2021 in Journal of Pharmaceutical Health Care and Sciences
Verified
Journal Article
Open access
PDF file
AMAsiye Moosivand
Asiye Moosivand
MRMaryam Rangchian
Maryam Rangchian
LZleila zarei
leila zarei
FPFarzad Peiravian
Farzad Peiravian
GMGholamhossein Mehralian
Gholamhossein Mehralian
HSHesameddin Sharifnia
Hesameddin Sharifnia
Background: Drug shortage is a significant public health problem, especially for drugs related to life threatening conditions. Almost all countries affected by variety of supply problems and spent a considerable amount of time and resources responding to shortage. The aim of present study is to determine and prioritize strategies to achieve best solutions for these considerable healthcare system challenges and to evaluate this strategies base on practical criteria. Methods: To achieve the study objectives, the research was conducted in two phases. Determining of the strategies to control drug shortage, and comprehensive assessments of priority of possible strategies. For each phase, a self-design questionnaire was developed. The five main managerial strategies dimensions including: regulatory, financial, supply chain, information system and policy-making were set out. Forty-five alternatives were elicited from literature, and were evaluated and trimmed to 37 strategies based on experts’ opinion. The Multiple criteria decision-making (MCDM) methods were applied in second phase. Five important criteria including cost, time, labor, compliance with law and culture were weighed by Analytic Hierarchy Process (AHP) technique. Then, 37 alternatives have been rated base on the five criteria on the Technique for Order of Preference by Similarity to Ideal Solution (TOPSIS) technique. Results: “Creating integrated Supply chain information system to manage medicines inventory in the country”, “Creating and using the databases to predict the shortage of medicines”, “Using track and trace system” are alternatives 20th, 24th and 25th, which related to supply chain (SC) and information system (IS) dimensions have higher priority in the experts’ point of view. The results show IS dimension has 100 percentage of priority; following that policy and supply chain have higher priority, respectively. Conclusion: Health systems rely on consistent supplying of pharmaceuticals to support patient care. The results show that information system, policy-making and supply chain are in the top-ranking priorities. Warning system needs to be improved to the advance system via better collaboration with stakeholders, publish precise and explicit national guidelines for drug shortage management, enforce the guidelines, and improve Iran FDA’s pharmaceutical market control capability.

8 January 2019 in PharmacoEconomics - Open
Verified
Journal Article
Open access
PDF file
NMNajmeh Moradi
Najmeh Moradi
ARArash Rashidian
Arash Rashidian
SNShirin Nosratnejad
Shirin Nosratnejad
AMAlireza Olyaee Manesh
Alireza Olyaee Manesh
MZMarzieh Zanganeh
Marzieh Zanganeh
LZleila zarei
leila zarei
A limited number of studies have specifically examined the value of quality-adjusted life-years (QALYs) from the patient’s perspective.